newsfilter
← Latest News
GlobeNewswire·

Viracta Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact